New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor models

Contemporary Clinical Trials

Volumn 33, Issue 1, 2012, Pages 178-183

  Medioni, Jacques ^a,b   Leuraud, Pascal ^c,d   Delattre, Jean Yves ^c   Poupon, Marie France ^d   Golmard, Jean Louis ^e  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSTITUT CURIE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM U612   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Drug evaluation; Mathematical model; Molecular biology; Preclinical; Xenograft model antitumor assays

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TELOMERASE; TEMOZOLOMIDE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENE MUTATION; GLIOBLASTOMA; GLIOMA; MATHEMATICAL MODEL; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PARAMETERS; TIME TO RELAPSE; TUMOR GROWTH; TUMOR GROWTH SPEED; TUMOR XENOGRAFT;

ANIMALS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; MODELS, THEORETICAL; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855346405     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.09.010     Document Type: Article

References (15)

1. Khleif S., Curt G. Animal models in developmental therapeutics. Cancer Medicine 2000, 573-584. Decker, London. 5th ed. H. Frei (Ed.).
2. Grieshaber C.K., Marsoni S. Relation of preclinical toxicology to findings in early clinical trials. Cancer Treat Rep 1986, 70(1):65-72.
3. Houghton P., Houghton J. Evaluation of single-agent therapy in human colorectal tumour xenografts. Br J Cancer 1978, 37:833-840.
4. Workman P., Balmain A., Hickman J., McNally N., Rohas A., Mitchison N., et al. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 1988, 22:195-201.
5. Mattern J., Bak M., Hahn E., Volm M. Human xenografts as model for drug testing. Cancer Metastasis Rev 1988, 7:263-288.
6. Begg A. Principles and practice of the tumor growth delay assay. Rodent tumor models in experimental cancer therapy 1987, 114. Pergamon Press, New York. R.K. Kallman (Ed.).
7. Gilewski T., Dang C., Surbonne A., Norton L. Cytokinetics. Cancer Medicine 2002, Decker, London. 6th ed. H. Frei (Ed.).
8. Leuraud P., Taillandier L., Medioni J., Aguirre-Cruz L., Criniere E., Marie Y., et al. Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. Cancer Res 2004, 64(13):4648-4653.
9. Skipper H., Schabel F.J., Wilcox W. Experimental evaluation of potential anticancer agents. Xiii. On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother Rep 1964, 35:1-111.
10. Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988, 48(24 Pt 1):7067-7071.
11. Luria S., Delbruck M. Mutation of bacteria from virus sensitivity to virus resistance. Genetics 1943, 28:491.
12. Kleihues P., Louis D., Scheithauer B., Rorke L., Reifenberger G., Burger P., et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61:215-225.
13. Shapiro W.R., Basler G.A., Chernik N.L., Posner J.B. Human brain tumor transplantation into nude mice. J Natl Cancer Inst 1979, 62(3):447-453.
14. Shorthouse A.J., Smyth J.F., Steel G.G., Ellison M., Mills J., Peckham M.J. The human tumour xenograft-a valid model in experimental chemotherapy?. Br J Surg 1980, 67(10):715-722.
15. Frank R., Hargreaves R. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2003, 2:566-580.